270 results on '"Zorg en O'
Search Results
102. Questionnaire- and linkage-based outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER study part 1
103. Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm
104. Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients
105. Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer (Nature Medicine, (2023), 29, 6, (1340-1348), 10.1038/s41591-023-02339-y)
106. Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study
107. Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial
108. Organizational characteristics of European pediatric onco-critical care: An international cross-sectional survey
109. Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors
110. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols
111. Artificial Intelligence in Pediatric Pathology: The Extinction of a Medical Profession or the Key to a Bright Future?
112. The fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries
113. Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma
114. Parents' experiences with large-scale sequencing for genetic predisposition in pediatric renal cancer: A qualitative study
115. Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'
116. Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy
117. MHC II - EGFP knock-in mouse model is a suitable tool for systems and quantitative immunology
118. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization
119. Progressive diastolic dysfunction in survivors of pediatric differentiated thyroid carcinoma
120. Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands
121. Body mass index at diagnosis of a childhood brain tumor; a reflection of hypothalamic-pituitary dysfunction or lifestyle?
122. Oncofertility Perspectives for Girls with Cancer
123. Childhood cancer survivorship care during the COVID-19 pandemic: an international report of practice implications and provider concerns
124. A Study on Prevalence and Determinants of Ototoxicity During Treatment of Childhood Cancer (SOUND): Protocol for a Prospective Study
125. Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia
126. Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line Therapy
127. High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort
128. Fasting Intervention for Children With Unilateral Renal Tumors to Reduce Toxicity
129. Progress against non-Hodgkin's lymphoma in children and young adolescents in the Netherlands since 1990: Stable incidence, improved survival and lower mortality
130. Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year's experience of national centralization
131. Thyroid function after diagnostic I-123-metaiodobenzylguanidine in children with neuroblastic tumors
132. Support needs of Dutch young adult childhood cancer survivors
133. Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire--a DCCSS LATER study
134. Prevalence and risk factors of cancer-related fatigue in childhood cancer survivors: A DCCSS LATER study
135. Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS
136. MRI Characteristics of Pediatric Renal Tumors: A SIOP-RTSG Radiology Panel Delphi Study
137. MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance
138. European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer
139. Overweight in the Dutch National Cohort of Long-Term Survivors of Childhood Cancer
140. Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood Cancer
141. Long-Term Effects of Childhood Cancer Treatment on Dentition and Oral Health: A Dentist Survey Study from the DCCSS LATER 2 Study
142. Locoregional Control Using Highly Conformal Flank Target Volumes and Volumetric-Modulated Arc Therapy in Pediatric Renal Tumors: Results from the Dutch National Cohort
143. Significant improvement in survival of advanced stage childhood and young adolescent cancer in the Netherlands since the 1990s
144. Characteristics and Outcome of Children with Renal Tumors in the Netherlands: First Five Year Single National Center Experience
145. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group
146. Prognostic factors for wilms tumor recurrence: A review of the literature
147. Inter-Clinician Delineation Variation for a New Highly-Conformal Flank Target Volume in Children with Renal Tumors: A Siop-Renal Tumor Study Group International Multicenter Exercise
148. Single cell derived mRNA signals across human kidney tumors
149. Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours
150. Interobserver variability between experienced and inexperienced observers in the histopathological analysis of Wilms tumors: a pilot study for future algorithmic approach
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.